New Progress of Epigenetic Biomarkers in Urological Cancer - Test2 - elhamkhani - TriplyDB

New Progress of Epigenetic Biomarkers in Urological Cancer

New Progress of Epigenetic Biomarkers in Urological Cancer

http://www.wikidata.org/entity/Q28073982

about

The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer.The stem cell factor (SCF)/c-KIT signalling in testis and prostate cancer.Elevation of Peripheral BDNF Promoter Methylation Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Longitudinal Study.Aberrant Promoter Methylation of Protocadherin8 (PCDH8) in Serum is a Potential Prognostic Marker for Low Gleason Score Prostate Cancer.A Versatile Assay for Detection of Aberrant DNA Methylation in Bladder Cancer.The suppressing role of miR-622 in renal cell carcinoma progression by down-regulation of CCL18/MAPK signal pathway.APOE hypermethylation is associated with autism spectrum disorder in a Chinese population.

P2860

Q39304639-27E7A24E-5C2D-47A0-976D-EB0430DAE1A4 Q39401758-191D4F12-3954-4D8D-B7BD-E6F9752EFF27 Q40432795-D8A5E66F-6715-4E61-A3A5-B01B3194EBEC Q42651317-367E046B-5C41-4908-98EF-E3007BCF429E Q46216442-056C5A6C-CBED-4519-9C82-62EBC227A252 Q52672936-BC260F74-361B-4EEB-8C5B-CE02226F7B42 Q55228994-D4E88F9B-01CB-4B80-A906-98B10E75B54D

P2860

New Progress of Epigenetic Biomarkers in Urological Cancer

http://www.wikidata.org/entity/Q28073982

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

New Progress of Epigenetic Biomarkers in Urological Cancer

@ast

New Progress of Epigenetic Biomarkers in Urological Cancer

@en

New Progress of Epigenetic Biomarkers in Urological Cancer

@nl

type

label

New Progress of Epigenetic Biomarkers in Urological Cancer

@ast

New Progress of Epigenetic Biomarkers in Urological Cancer

@en

New Progress of Epigenetic Biomarkers in Urological Cancer

@nl

prefLabel

New Progress of Epigenetic Biomarkers in Urological Cancer

@ast

New Progress of Epigenetic Biomarkers in Urological Cancer

@en

New Progress of Epigenetic Biomarkers in Urological Cancer

@nl

P1433

Q28073982-7E49EE30-3B4B-4C7B-9F29-3ED5FDDAC6A4

P1476

Q28073982-5EE2A195-CF5D-40E5-AE12-7C50FD655525

P2093

Q28073982-BFD40B12-5EDE-41F8-8C13-96AD88CE510E

P275

Q28073982-5C149C75-2D21-4EFD-9072-D006EDC97F77

P2860

Q28073982-0607D550-A578-4DAF-B2EB-33588D590656

Q28073982-0D5FA9CF-FBBE-4951-B160-E20407A6C0B0

Q28073982-10D6A131-1132-479D-8763-4D0AD8E11758

Q28073982-19A45DF0-FB87-452B-81A1-8D346CC9DBD5

Q28073982-1DB0519E-8DF3-4C38-9DE7-3CFB7514139E

Q28073982-217FBA1C-2F73-4C0A-9EE1-3B87819CB47A

Q28073982-219CEB0F-099F-450C-914C-38189B59FB9F

Q28073982-2557D77E-BAD0-40FF-B0E0-991234633123

Q28073982-273F0ECA-7E9C-4962-9A5E-4F4A3B5AAC64

Q28073982-2AD1E257-FC27-47BD-8FD1-42C739A6983E

P304

Q28073982-7B4E38A4-8094-4614-9447-A649D69EA3C8

P31

Q28073982-26980D9A-806E-4B87-ABFC-7A64C5325066

Q28073982-B4BD8CB0-E65C-4A62-9EC9-2DAF8BB6D668

P3181

Q28073982-D776CAE8-D7C6-4593-BA35-A4C0F424DB30

P356

Q28073982-67E84BB6-3B26-4BCA-87A5-893D8C485F99

P407

Q28073982-9DB4B938-464B-4751-9054-BEA4624F7108

P478

Q28073982-ED37FD2C-2D1F-48BF-AB2E-E451D89E058B

P50

Q28073982-3FE306E1-1876-4F9F-A2AB-562074A781C0

Q28073982-812B8095-AB11-4118-9BB8-965E0E37FD5E

P5008

Q28073982-51E3EAEC-1326-4AF6-A1E4-CA0E97F3D98A

P577

Q28073982-51701A90-CAFF-4A1E-BD3E-90B9FFBFEB2B

P698

Q28073982-81592B19-71EF-42B2-9772-3DDE9D2DD37F

P921

Q28073982-51BCA0D0-4A45-4BA9-9F65-984F64E3CC9E

Q28073982-52AA7CDE-19A3-488C-9C84-4A64CEEED1DF

Q28073982-7A6046A8-ECFB-4D14-BE21-547E6EE0920C

Q28073982-A063E101-AF02-4AFD-BAE7-313DEADFA3CA

Q28073982-C332C67F-20F0-4599-BCBA-933274C3054F

P932

Q28073982-BDC324CB-86A7-414F-9FB2-C08FF143B676

P3181

P356

P1433

Disease Markers

P1476

New Progress of Epigenetic Biomarkers in Urological Cancer

@en

P2093

Ziyi Cao

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

RNAi-mediated pathways in the nucleus

Engrailed-2 (EN2): a tumor specific urinary biomarker for the early diagnosis of prostate cancer

Epigenetics: a landscape takes shape

Epigenetics in cancer

LINE-1 methylation is inherited in familial testicular cancer kindreds.

Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer.

Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance.

Rapid phenotypic and genomic change in response to therapeutic pressure in prostate cancer inferred by high content analysis of single circulating tumor cells

Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer.

MicroRNAs in human cancer.

P304

9864047

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4175081

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2016/9864047

http://www.w3.org/2001/XMLSchema#string

P407

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2016-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27594736

http://www.w3.org/2001/XMLSchema#string

P921

urinary system benign neoplasm

regulation of gene expression

urinary system neoplasm

tumor biomarkers

P932

4993951

http://www.w3.org/2001/XMLSchema#string